EIF3H knockdown inhibits malignant melanoma through regulating cell proliferation, apoptosis and cell cycle

Exp Cell Res. 2021 May 1;402(1):112488. doi: 10.1016/j.yexcr.2021.112488. Epub 2021 Jan 26.

Abstract

Malignant melanoma (MM) causes 80% of skin cancer-related deaths and becomes the most lethal type of skin cancer. The molecular mechanism of MM is still not clear. This study aimed to reveal the relationship between MM and EIF3H. Clinical specimens were collected to preliminarily explore the role of EIF3H in MM. MM cell lines with EIF3H knockdown were constructed for investigating the effects of EIF3H on cell proliferation, apoptosis, cell cycle and cell motility. Mice xenograft model was constructed for verification in vivo. We found that EIF3H was obviously upregulated in MM tissues compared with normal skin tissues, which was correlated with tumor stage and risk of lymphatic metastasis. The in vitro results indicated that silencing EIF3H in MM cells could significantly suppress cell proliferation, promote cell apoptosis and induce cell cycle arrest. Moreover, EIF3H knockdown significantly restrained cell motility through regulating EMT-related proteins. The effects of EIF3H knockdown were also verified in mice xenograft model, which were represented by slower growth rate, smaller volume and lighter weight of tumors. Therefore, EIF3H was identified as a critical factor in the development and progression of MM which may be used as a novel therapeutic target in the treatment of MM.

Keywords: Cell apoptosis; Cell proliferation; EIF3H; EMT; Malignant melanoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / genetics
  • Biomarkers, Tumor / genetics*
  • Cell Cycle / genetics
  • Cell Line, Tumor
  • Cell Proliferation / genetics*
  • Eukaryotic Initiation Factor-3 / genetics*
  • Female
  • Gene Expression Regulation, Neoplastic / genetics
  • Gene Knockdown Techniques
  • Humans
  • Lymphatic Metastasis
  • Male
  • Melanoma / genetics*
  • Melanoma / pathology
  • Mice
  • Middle Aged
  • Xenograft Model Antitumor Assays

Substances

  • Biomarkers, Tumor
  • Eukaryotic Initiation Factor-3
  • EIF3I protein, human